Alnylam Pharmaceuticals
ALNY
ALNY
449 hedge funds and large institutions have $20.9B invested in Alnylam Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 162 increasing their positions, 162 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
449
Holders Change
-23
Holders Change %
-4.87%
% of All Funds
7.16%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
43
Increased
162
Reduced
162
Closed
58
Calls
$172M
Puts
$203M
Net Calls
-$30.3M
Net Calls Change
+$11.9M
Top Buyers
Top Sellers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$2B |
| 2 |
2
Morgan Stanley
New York
|
$214M |
| 3 |
3
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$1.45B |
| 4 |
4
Two Sigma Investments
New York
|
$584K |
| 5 |
5
Invesco
Atlanta,
Georgia
|
$38.4M |
